O	0	12	Neurotrophin	Neurotrophin	NN	B-NP
O	13	16	p75	p75	NN	I-NP
O	17	25	receptor	receptor	NN	I-NP
O	26	27	(	(	(	O
O	27	33	p75NTR	p75NTR	NN	B-NP
O	33	34	)	)	)	O
O	35	43	promotes	promote	VBZ	B-VP
B-Cell	44	55	endothelial	endothelial	JJ	B-NP
I-Cell	56	60	cell	cell	NN	I-NP
O	61	70	apoptosis	apoptosis	NN	I-NP
O	71	74	and	and	CC	O
O	75	83	inhibits	inhibit	VBZ	B-VP
O	84	96	angiogenesis	angiogenesis	NN	B-NP
O	96	97	:	:	:	O
O	98	110	implications	implication	NNS	B-NP
O	111	114	for	for	IN	B-PP
O	115	123	diabetes	diabetes	NN	B-NP
O	123	124	-	-	HYPH	B-NP
O	124	131	induced	induce	VBN	I-NP
O	132	140	impaired	impair	VBN	I-NP
O	141	159	neovascularization	neovascularization	NN	I-NP
O	160	162	in	in	IN	B-PP
O	163	171	ischemic	ischemic	JJ	B-NP
B-Organ	172	176	limb	limb	NN	I-NP
I-Organ	177	184	muscles	muscle	NNS	I-NP
O	184	185	.	.	.	O

O	186	194	Diabetes	Diabetes	NNP	B-NP
O	195	202	impairs	impair	VBZ	B-VP
B-Cell	203	214	endothelial	endothelial	JJ	B-NP
O	215	223	function	function	NN	I-NP
O	224	227	and	and	CC	O
O	228	238	reparative	reparative	JJ	B-NP
O	239	257	neovascularization	neovascularization	NN	I-NP
O	257	258	.	.	.	O

O	259	262	The	The	DT	B-NP
O	263	266	p75	p75	NN	I-NP
O	267	275	receptor	receptor	NN	I-NP
O	276	278	of	of	IN	B-PP
O	279	292	neurotrophins	neurotrophin	NNS	B-NP
O	293	294	(	(	(	O
O	294	297	p75	p75	NN	B-NP
O	297	298	(	(	(	O
O	298	301	NTR	NTR	NN	B-NP
O	301	302	)	)	)	O
O	302	303	)	)	)	O
O	303	304	,	,	,	O
O	305	310	which	which	WDT	B-NP
O	311	313	is	be	VBZ	B-VP
O	314	322	scarcely	scarcely	RB	B-ADJP
O	323	330	present	present	JJ	I-ADJP
O	331	333	in	in	IN	B-PP
O	334	341	healthy	healthy	JJ	B-NP
B-Cell	342	353	endothelial	endothelial	JJ	I-NP
I-Cell	354	359	cells	cell	NNS	I-NP
O	360	361	(	(	(	O
B-Cell	361	364	ECs	EC	NNS	B-NP
O	364	365	)	)	)	O
O	365	366	,	,	,	O
O	367	374	becomes	become	VBZ	B-VP
O	375	383	strongly	strongly	RB	I-VP
O	384	393	expressed	express	VBN	I-VP
O	394	396	by	by	IN	B-PP
B-Cell	397	406	capillary	capillary	JJ	B-NP
I-Cell	407	410	ECs	EC	NNS	I-NP
O	411	416	after	after	IN	B-PP
O	417	426	induction	induction	NN	B-NP
O	427	429	of	of	IN	B-PP
B-Tissue	430	440	peripheral	peripheral	JJ	B-NP
O	441	449	ischemia	ischemia	NN	I-NP
O	450	452	in	in	IN	B-PP
O	453	457	type	type	NN	B-NP
O	457	458	-	-	HYPH	B-NP
O	458	459	1	1	CD	I-NP
O	460	468	diabetic	diabetic	JJ	I-NP
O	469	473	mice	mouse	NNS	I-NP
O	473	474	.	.	.	O

O	475	479	Here	Here	RB	B-ADVP
O	479	480	,	,	,	O
O	481	483	we	we	PRP	B-NP
O	484	488	show	show	VBP	B-VP
O	489	493	that	that	IN	B-SBAR
O	494	498	gene	gene	NN	B-NP
O	499	507	transfer	transfer	NN	I-NP
O	507	508	-	-	HYPH	B-VP
O	508	515	induced	induce	VBN	B-NP
O	516	519	p75	p75	NN	I-NP
O	519	520	(	(	(	O
O	520	523	NTR	NTR	NN	B-NP
O	523	524	)	)	)	O
O	525	535	expression	expression	NN	B-NP
O	536	543	impairs	impair	VBZ	B-VP
O	544	547	the	the	DT	B-NP
O	548	556	survival	survival	NN	I-NP
O	556	557	,	,	,	O
O	558	571	proliferation	proliferation	NN	B-NP
O	571	572	,	,	,	O
O	573	582	migration	migration	NN	B-NP
O	582	583	,	,	,	O
O	584	587	and	and	CC	O
O	588	596	adhesion	adhesion	NN	B-NP
O	597	607	capacities	capacity	NNS	I-NP
O	608	610	of	of	IN	B-PP
O	611	619	cultured	culture	VBN	B-NP
B-Cell	620	623	ECs	EC	NNS	I-NP
O	624	627	and	and	CC	O
B-Cell	628	639	endothelial	endothelial	JJ	B-NP
I-Cell	640	650	progenitor	progenitor	NN	I-NP
I-Cell	651	656	cells	cell	NNS	I-NP
O	657	658	(	(	(	O
B-Cell	658	662	EPCs	EPC	NNS	B-NP
O	662	663	)	)	)	O
O	664	667	and	and	CC	O
O	668	676	inhibits	inhibit	VBZ	B-VP
O	677	689	angiogenesis	angiogenesis	NN	B-NP
O	690	692	in	in	FW	B-ADVP
O	693	698	vitro	vitro	FW	I-ADVP
O	698	699	.	.	.	O

O	700	708	Moreover	Moreover	RB	B-ADVP
O	708	709	,	,	,	O
B-Immaterial_anatomical_entity	710	723	intramuscular	intramuscular	JJ	B-NP
O	724	727	p75	p75	NN	I-NP
O	727	728	(	(	(	O
O	728	731	NTR	NTR	NN	B-NP
O	731	732	)	)	)	O
O	733	737	gene	gene	NN	B-NP
O	738	746	delivery	delivery	NN	I-NP
O	747	754	impairs	impair	VBZ	B-VP
O	755	773	neovascularization	neovascularization	NN	B-NP
O	774	777	and	and	CC	I-NP
B-Organism_substance	778	783	blood	blood	NN	I-NP
O	784	788	flow	flow	NN	I-NP
O	789	797	recovery	recovery	NN	I-NP
O	798	800	in	in	IN	B-PP
O	801	802	a	a	DT	B-NP
O	803	808	mouse	mouse	NN	I-NP
O	809	814	model	model	NN	I-NP
O	815	817	of	of	IN	B-PP
B-Organism_subdivision	818	822	limb	limb	NN	B-NP
O	823	831	ischemia	ischemia	NN	I-NP
O	831	832	.	.	.	O

O	833	838	These	These	DT	B-NP
O	839	848	disturbed	disturbed	JJ	I-NP
O	849	858	functions	function	NNS	I-NP
O	859	862	are	be	VBP	B-VP
O	863	873	associated	associate	VBN	I-VP
O	874	878	with	with	IN	B-PP
O	879	890	suppression	suppression	NN	B-NP
O	891	893	of	of	IN	B-PP
O	894	903	signaling	signaling	NN	B-NP
O	904	914	mechanisms	mechanism	NNS	I-NP
O	915	925	implicated	implicate	VBN	B-VP
O	926	928	in	in	IN	B-PP
B-Cell	929	931	EC	EC	NN	B-NP
O	932	940	survival	survival	NN	I-NP
O	941	944	and	and	CC	I-NP
O	945	957	angiogenesis	angiogenesis	NN	I-NP
O	957	958	.	.	.	O

O	959	961	In	In	IN	B-PP
O	962	966	fact	fact	NN	B-NP
O	966	967	,	,	,	O
O	968	971	p75	p75	NN	B-NP
O	971	972	(	(	(	O
O	972	975	NTR	NTR	NN	B-NP
O	975	976	)	)	)	O
O	977	986	depresses	depress	VBZ	B-VP
O	987	990	the	the	DT	B-NP
O	991	995	VEGF	VEGF	NN	I-NP
O	995	996	-	-	HYPH	I-NP
O	996	997	A	A	NN	I-NP
O	997	998	/	/	SYM	I-NP
O	998	1001	Akt	Akt	NN	I-NP
O	1001	1002	/	/	SYM	B-NP
O	1002	1006	eNOS	eNOS	NN	I-NP
O	1006	1007	/	/	SYM	I-NP
O	1007	1009	NO	NO	NN	I-NP
O	1010	1017	pathway	pathway	NN	I-NP
O	1018	1021	and	and	CC	O
O	1022	1034	additionally	additionally	RB	B-VP
O	1035	1042	reduces	reduce	VBZ	I-VP
O	1043	1046	the	the	DT	B-NP
O	1047	1051	mRNA	mRNA	NN	I-NP
O	1052	1058	levels	level	NNS	I-NP
O	1059	1061	of	of	IN	B-PP
O	1062	1067	ITGB1	ITGB1	NN	B-NP
O	1068	1069	[	[	(	O
O	1069	1073	beta	beta	NN	B-NP
O	1074	1075	(	(	(	O
O	1075	1076	1	1	CD	B-NP
O	1076	1077	)	)	)	O
O	1078	1086	integrin	integrin	NN	B-NP
O	1086	1087	]	]	)	O
O	1087	1088	,	,	,	O
O	1089	1094	BIRC5	BIRC5	NN	B-NP
O	1095	1096	(	(	(	O
O	1096	1104	survivin	survivin	NN	B-NP
O	1104	1105	)	)	)	O
O	1105	1106	,	,	,	O
O	1107	1112	PTTG1	PTTG1	NN	B-NP
O	1113	1114	(	(	(	O
O	1114	1121	securin	securin	NN	B-NP
O	1121	1122	)	)	)	O
O	1123	1126	and	and	CC	O
O	1127	1132	VEZF1	VEZF1	NN	B-NP
O	1132	1133	.	.	.	O

O	1134	1142	Diabetic	Diabetic	JJ	B-NP
O	1143	1147	mice	mouse	NNS	I-NP
O	1147	1148	,	,	,	O
O	1149	1154	which	which	WDT	B-NP
O	1155	1164	typically	typically	RB	B-ADVP
O	1165	1169	show	show	VBP	B-VP
O	1170	1178	impaired	impaired	JJ	B-NP
O	1179	1191	postischemic	postischemic	JJ	I-NP
B-Organ	1192	1200	muscular	muscular	JJ	I-NP
O	1201	1219	neovascularization	neovascularization	NN	I-NP
O	1220	1223	and	and	CC	I-NP
B-Organism_substance	1224	1229	blood	blood	NN	I-NP
O	1230	1239	perfusion	perfusion	NN	I-NP
O	1240	1248	recovery	recovery	NN	I-NP
O	1248	1249	,	,	,	O
O	1250	1254	have	have	VBP	B-VP
O	1255	1260	these	these	DT	B-NP
O	1261	1268	defects	defect	NNS	I-NP
O	1269	1278	corrected	correct	VBN	B-VP
O	1279	1281	by	by	IN	B-PP
B-Immaterial_anatomical_entity	1282	1295	intramuscular	intramuscular	JJ	B-NP
O	1296	1300	gene	gene	NN	I-NP
O	1301	1309	transfer	transfer	NN	I-NP
O	1310	1312	of	of	IN	B-PP
O	1313	1314	a	a	DT	B-NP
O	1315	1323	dominant	dominant	JJ	I-NP
O	1324	1332	negative	negative	JJ	I-NP
O	1333	1339	mutant	mutant	JJ	I-NP
O	1340	1344	form	form	NN	I-NP
O	1345	1347	of	of	IN	B-PP
O	1348	1351	p75	p75	NN	B-NP
O	1351	1352	(	(	(	O
O	1352	1355	NTR	NTR	NN	B-NP
O	1355	1356	)	)	)	O
O	1356	1357	.	.	.	O

O	1358	1370	Collectively	Collectively	RB	B-ADVP
O	1370	1371	,	,	,	O
O	1372	1375	our	our	PRP$	B-NP
O	1376	1380	data	datum	NNS	I-NP
O	1381	1386	newly	newly	RB	B-ADVP
O	1387	1398	demonstrate	demonstrate	VBP	B-VP
O	1399	1402	the	the	DT	B-NP
O	1403	1417	antiangiogenic	antiangiogenic	JJ	I-NP
O	1418	1424	action	action	NN	I-NP
O	1425	1427	of	of	IN	B-PP
O	1428	1431	p75	p75	NN	B-NP
O	1431	1432	(	(	(	O
O	1432	1435	NTR	NTR	NN	B-NP
O	1435	1436	)	)	)	O
O	1437	1440	and	and	CC	O
O	1441	1445	open	open	JJ	B-NP
O	1446	1449	new	new	JJ	I-NP
O	1450	1457	avenues	avenue	NNS	I-NP
O	1458	1461	for	for	IN	B-PP
O	1462	1465	the	the	DT	B-NP
O	1466	1477	therapeutic	therapeutic	JJ	I-NP
O	1478	1481	use	use	NN	I-NP
O	1482	1484	of	of	IN	B-PP
O	1485	1488	p75	p75	NN	B-NP
O	1488	1489	(	(	(	O
O	1489	1492	NTR	NTR	NN	B-NP
O	1492	1493	)	)	)	O
O	1494	1504	inhibition	inhibition	NN	B-NP
O	1505	1507	to	to	TO	B-VP
O	1508	1514	combat	combat	VB	I-VP
O	1515	1523	diabetes	diabetes	NN	B-NP
O	1523	1524	-	-	HYPH	O
O	1524	1531	induced	induce	VBN	B-NP
B-Tissue	1532	1545	microvascular	microvascular	JJ	I-NP
O	1546	1557	liabilities	liability	NNS	I-NP
O	1557	1558	.	.	.	O

